Immuron to host live virtual event

Melbourne, australia, april 15, 2024 (globe newswire) -- immuron limited (asx: imc; nasdaq: imrn), an australian based and globally integrated biopharmaceutical company is pleased to advise our chief executive officer, steven lydeamore together with our chief scientific officer, dr. jerry kanellos and research & development manager, dr. joanne casey will be hosting a live virtual event on tuesday, april 30 at 10am aest / monday, april 29 at 8pm edt.
IMRN Ratings Summary
IMRN Quant Ranking